Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It is widely studied in endocrinology and molecular biology research for its selective activation of the growth hormone secretagogue receptor (GHSR), also known as the ghrelin receptor.
In laboratory and preclinical research settings, ipamorelin is examined for its effects on growth hormone pulsatility, hypothalamic–pituitary axis signaling, and downstream pathways involving insulin-like growth factor-1 (IGF-1). Compared to other secretagogues, ipamorelin is often studied for its more selective growth hormone–related signaling with minimal involvement of other pituitary hormones.
Research involving ipamorelin focuses on receptor-mediated endocrine signaling, growth hormone regulation mechanisms, and metabolic pathway interactions rather than therapeutic or clinical application.
